Early metabolomic, lipid and lipoprotein changes in response to medical and surgical therapeutic approaches to obesity

Roux-En-Y Gastric Bypass (RYGB) Surgery during High Liquid Sucrose Diet Leads to Gut Microbiota-Related Systematic Alterations

(2022) Laimdota Zizmare et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Neurohormonal Changes in the Gut–Brain Axis and Underlying Neuroendocrine Mechanisms following Bariatric Surgery

(2022) Eirini Martinou et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Epitranscriptomic challenges and promises in metabolic diseases

(2022) Despina Sanoudou et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Glucagon‐like peptide‐1 (GLP‐1) receptor agonists and their cardiovascular benefits—The role of the GLP‐1 receptor

(2021) Johanna Helmstädter et al.   BRITISH JOURNAL OF PHARMACOLOGY

Cardiovascular Disease in Chronic Kidney Disease

(2021) Joachim Jankowski et al.   CIRCULATION

Short-term changes in the serum metabolome after laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass

(2021) Gakyung Lee et al.   Metabolomics

Metabolomics in Bariatric Surgery: Towards Identification of Mechanisms and Biomarkers of Metabolic Outcomes

(2021) Jane Ha et al.   OBESITY SURGERY

Surgical, metabolic, and prognostic outcomes for Roux-en-Y gastric bypass versus sleeve gastrectomy: a systematic review

(2021) Evander Meneses et al.   Surgery for Obesity and Related Diseases

Pharmacometabolomic profiles in type 2 diabetic subjects treated with liraglutide or glimepiride

(2021) J. Jendle et al.   Cardiovascular Diabetology

Novel Noninvasive Approaches to the Treatment of Obesity: From Pharmacotherapy to Gene Therapy

(2021) Angeliki M Angelidi et al.   ENDOCRINE REVIEWS

Metabolomic signatures after bariatric surgery – a systematic review

(2021) Matilde Vaz et al.   REVIEWS IN ENDOCRINE & METABOLIC DISORDERS

The “Virtual Digital Twins” Concept in Precision Nutrition

(2020) Kalliopi Gkouskou et al.   Advances in Nutrition

A Newly Developed Diabetes Risk Index, Based on Lipoprotein Subfractions and Branched Chain Amino Acids, is Associated with Incident Type 2 Diabetes Mellitus in the PREVEND Cohort

(2020) Jose L. Flores-Guerrero et al.   Journal of Clinical Medicine

Effect of liraglutide on estimates of lipolysis and lipid oxidation in obese patients with stable coronary artery disease and newly diagnosed type 2 diabetes: A randomized trial

(2019) Christian Anholm et al.   DIABETES OBESITY & METABOLISM

Longer‐term liraglutide administration at the highest dose approved for obesity increases reward‐related orbitofrontal cortex activations to food cues: Implications for plateauing weight loss in response to anti‐obesity therapies

(2019) Olivia M. Farr et al.   DIABETES OBESITY & METABOLISM

1H NMR spectroscopy quantifies visibility of lipoproteins, subclasses, and lipids at varied temperatures and pressures

(2019) Daniela Baumstark et al.   JOURNAL OF LIPID RESEARCH

Effects of liraglutide on lipolysis and the AC3/PKA/HSL pathway

(2019) Zhengming Li et al.   Diabetes Metabolic Syndrome and Obesity-Targets and Therapy

Short-term treatment with high dose liraglutide improves lipid and lipoprotein profile and changes hormonal mediators of lipid metabolism in obese patients with no overt type 2 diabetes mellitus: a randomized, placebo-controlled, cross-over, double-blind clinical trial

(2019) Natia Peradze et al.   Cardiovascular Diabetology

Circulating levels of gastrointestinal hormones in response to the most common types of bariatric surgery and predictive value for weight loss over one year: Evidence from two independent trials

(2019) Nikolaos Perakakis et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1

(2018) Daniel J. Drucker   Cell Metabolism

Application of Metabolomics to Study Effects of Bariatric Surgery

(2018) Paulina Samczuk et al.   Journal of Diabetes Research

Liraglutide treatment improves postprandial lipid metabolism and cardiometabolic risk factors in humans with adequately controlled type 2 diabetes: A single-centre randomized controlled study

(2018) Niina Matikainen et al.   DIABETES OBESITY & METABOLISM

Omics, big data and machine learning as tools to propel understanding of biological mechanisms and to discover novel diagnostics and therapeutics

(2018) Nikolaos Perakakis et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Long-term weight change and health outcomes for sleeve gastrectomy (SG) and matched Roux-en-Y gastric bypass (RYGB) participants in the Longitudinal Assessment of Bariatric Surgery (LABS) study

(2018) Bestoun Ahmed et al.   SURGERY

Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics

(2018) Stergios A. Polyzos et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Pharmacotherapy of obesity: Available medications and drugs under investigation

(2018) Eleni Pilitsi et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Weight and Metabolic Outcomes 12 Years after Gastric Bypass

(2017) Ted D. Adams et al.   NEW ENGLAND JOURNAL OF MEDICINE

GLP-1 receptors exist in the parietal cortex, hypothalamus and medulla of human brains and the GLP-1 analogue liraglutide alters brain activity related to highly desirable food cues in individuals with diabetes: a crossover, randomised, placebo-controlled trial

(2016) Olivia M. Farr et al.   DIABETOLOGIA

Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants

(2016)   LANCET

Major Increase in Microbiota-Dependent Proatherogenic Metabolite TMAO One Year After Bariatric Surgery

(2016) Marius Trøseid et al.   Metabolic Syndrome and Related Disorders

Central nervous system regulation of eating: Insights from human brain imaging

(2016) Olivia M. Farr et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

(2016) Steven P. Marso et al.   NEW ENGLAND JOURNAL OF MEDICINE

Roux-en-Y Gastric Bypass and Vertical Banded Gastroplasty Induce Long-Term Changes on the Human Gut Microbiome Contributing to Fat Mass Regulation

(2015) Valentina Tremaroli et al.   Cell Metabolism

Metabolomic insights into the intricate gut microbial–host interaction in the development of obesity and type 2 diabetes

(2015) Magali Palau-Rodriguez et al.   Frontiers in Microbiology

Effects of Bariatric Surgery on Hepatic and Intestinal Lipoprotein Particle Metabolism in Obese, Nondiabetic Humans

(2014) Nadège Padilla et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

NMR measurement of LDL particle number using the Vantera® Clinical Analyzer

(2014) Steven P. Matyus et al.   CLINICAL BIOCHEMISTRY

Lipoprotein Insulin Resistance Index: A Lipoprotein Particle–Derived Measure of Insulin Resistance

(2014) Irina Shalaurova et al.   Metabolic Syndrome and Related Disorders

Reductions in lipids and CV risk markers in patients with type 2 diabetes treated with liraglutide: a meta-analysis

(2012) J. Plutzky et al.   Canadian Journal of Diabetes

Health Benefits of Gastric Bypass Surgery After 6 Years

(2012) Ted D. Adams et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Improvement in Cardiovascular Indices After Roux-en-Y Gastric Bypass or Sleeve Gastrectomy for Morbid Obesity

(2012) Alexander Kokkinos et al.   OBESITY SURGERY

Bariatric Surgery: Metabolic Benefits Beyond Weight Loss

(2011) Rexford S. Ahima et al.   GASTROENTEROLOGY

Dysregulation of lipolysis and lipid metabolism in visceral and subcutaneous adipocytes by high-fat diet: role of ATGL, HSL, and AMPK

(2010) Mandeep P. Gaidhu et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY